Sign up to save your podcasts
Or
Share Episode 61: Personalising Anti-VEGF Treatment in Neovascular AMD: Does Phenotype Matter?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 61: Personalising Anti-VEGF Treatment in Neovascular AMD: Does Phenotype Matter?
Dr. Sarah Mrejen (France), Associate Professor Salomon Cohen (France), and Associate Professor Dinah Zur (Israel) explore how neovascular AMD phenotype may influence imaging choices, patient dialogue, and treatment plans. From proactive vs. conservative strategies to new anti-VEGF agents and PCV diagnosis, this expert-led discussion offers key insights into personalising care in retinal disease.
View all episodes
By Whipsmart Media
5
11 ratings
Dr. Sarah Mrejen (France), Associate Professor Salomon Cohen (France), and Associate Professor Dinah Zur (Israel) explore how neovascular AMD phenotype may influence imaging choices, patient dialogue, and treatment plans. From proactive vs. conservative strategies to new anti-VEGF agents and PCV diagnosis, this expert-led discussion offers key insights into personalising care in retinal disease.
More shows like Talking Euretina
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
99 Listeners
New Retina Radio by Eyetube
17 Listeners
ESCRS Podcasts
1 Listeners
CRST: The Podcast
8 Listeners
EL MUNDO al día
33 Listeners
Experts InSight
49 Listeners
RETINA Journal Podcasts
10 Listeners
Ophthalmology Journal
17 Listeners
Mayo Clinic Ophthalmology Podcast
16 Listeners
Cataract Coach with Uday Devgan MD
16 Listeners
The Rest Is Politics: Leading
989 Listeners
RetinaRounds™
0 Listeners